Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00290459 · ClinicalTrials.gov registry record
Prognostic Markers of Gynecologic Cancers
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 1,321
- Enrollment target
NCT00290459 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 1,321 participants.
The verdict
NCT00290459 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 1,321 participants
- Enrollment target
Study Summary
This proposal seeks to retain "discard" pieces of human gynecologic tissues and "discard" ascites fluid collected during normal surgical procedures, along with corresponding blood samples and urine, for research involving prognostic markers of disease/cancer. The specific aims of the proposal include: 1. To collect "discard" pieces of benign, pre-malignant and malignant gynecologic tissues, "discard" ascites fluid and, when possible, corresponding blood and urine specimens from patients undergoing: 1. hysterectomy 2. excisions of cervical dysplasia and/or venereal warts, and 3. therapeutic excisional surgeries to remove gynecologic disease/cancer (uterine, ovarian and lower female genital tract). 4. paracentesis for the symptomatic relief of ascites fluid accumulation (distention). 2. To collect pre-operative blood and urine from patients along with pre- operative blood work drawn for clinical evaluation. 3. De-identify the patients from their donated tissue, blood and urine specimens by assigning a laboratory identification number. 4. Rapidly process and store the collected specimens to preserve biological integrity. (RNA, DNA and proteins) 5. Collect and record the patient's demographic and medical information into a research database under the assigned lab number only. 6. Assess the specimens for prognostic markers of gynecologic disease/cancer by molecular techniques such as DNA arrays,immunohistochemistry and ELISA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,321 participants |
| Start Date | 2003-12 |
| Est. Completion | 2021-03-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00290459
The ClinicalTrials.gov registry entry for NCT00290459 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,321 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00290459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00290459 about?
NCT00290459 is a clinical study titled "Prognostic Markers of Gynecologic Cancers". This proposal seeks to retain "discard" pieces of human gynecologic tissues and "discard" ascites fluid collected during normal surgical procedures, along with corresponding blood samples and urine, for research involving prognostic markers of disease/cancer. The specific aims of the proposal includ...
What is the current status of trial NCT00290459?
This trial is currently completed. The enrollment target is 1,321 participants. The study started on 2003-12. Estimated completion is 2021-03-26.
Who is sponsoring clinical trial NCT00290459?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.